19 Jun 2024 | 12:03 PM UTC
Canada: Elevated meningococcal disease activity reported in Manitoba in June
Elevated meningococcal disease activity reported in Manitoba, Canada, in June. Obtain vaccination; use basic health precautions.
Canadian health authorities have reported elevated meningococcal disease activity in Manitoba Province since Dec. 21, 2023, with 19 total cases reported as of June 14. The province reported an average of six cases in previous years. This year, eight cases were reported in May alone. Health officials in Manitoba updated the recommended vaccine from Men-C-C to Men-C-ACYW for infants 12 months of age. This report represents the most complete data available as of June 19.
Visit a doctor to ensure vaccination against meningococcal disease. Practice basic health precautions. Seek medical attention if symptoms develop within two weeks of being in affected areas.
Meningococcal disease, also called bacterial meningitis, is a bacterial disease that spreads through respiratory droplets created when an infected individual coughs, sneezes, or speaks. Disease transmission usually requires close or lengthy contact with an infected individual. Symptoms typically appear 3-4 days after exposure, but can develop up to 10 days after exposure. The most common symptoms of meningococcal disease are a stiff neck, high fever, sensitivity to light, confusion, headaches, and vomiting.
